With multiple novel therapies expected and the treatment paradigm shifting toward earlier intervention, the market will grow ...

Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Regeneron Pharmaceuticals is conducting a clinical study ...

Dupilumab may provide a nonsteroidal option for managing cancer therapy-related skin toxicities, according to a study.